## Abstract Vaccines based on human papillomavirus (HPV) 16 and 18 virusβlike particles have the potential to prevent βΌ70% of cervical cancers. In Australia, public vaccination against HPV commenced in April 2007, and includes routine vaccination of females aged 12β13 years, and a 2βyear school and
Impact of human papillomavirus vaccination depends on effective vaccination strategy
β Scribed by Matti Lehtinen; Jorma Paavonen
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 45 KB
- Volume
- 125
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Highβrisk human papillomaviruses (HRβHPVs) are the causative agents of cervical cancer and prophylactic HPV vaccination has been recommended for adolescents but no data are available on the prevalence of HPV infection among adolescents in India. Selfβcollected midstream urine samples fr
TABLE 1 Results From an Ad Hoc Meeting Conducted by the Pan American Health Organization on Important Biologic Endpoints for Human Papillomavirus Vaccine Surveillance Endpoints for HPV Surveillance and Measurement Indicators Endpoint Measurement Indicator Genital HPV infections Changes in prevalence
## Abstract The aim of this study was to determine the proportion of invasive cervical cancers attributable to human papillomavirus (HPV) types 16 and 18 in a contemporary, cytologically wellβscreened UK population. This was achieved in a retrospective observational analysis by HPV typing 453 archi